BLCONYSEOphthalmic GoodsFiscal year ends December 31
Bausch & Lomb Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$16.61+0.12 (+0.73%)
Close on Oct 19, 2026
- Market cap
- $5.93B
- P/E (TTM)
- –
- Dividend yield
- –
Bausch & Lomb statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Ophthalmic Goods companies for comparison
Valuation
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Market Cap | $5.93B | $230.55M |
| Enterprise Value | $10.71B | $202.97M |
| PS Ratio | 1.11 | 3.11 |
| PB Ratio | 0.93 | 3.14 |
| P/FCF Ratio | 43.30 | 27.25 |
| P/OCF Ratio | 12.95 | 22.35 |
Enterprise value
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| EV / Sales | 2.01 | 2.92 |
| EV / EBITDA | 14.59 | 19.86 |
| EV / EBIT | 33.16 | 24.88 |
| EV / FCF | 78.18 | 27.85 |
Income (trailing twelve months)
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Revenue | $5.32B | $102.39M |
| Operating Income | $323.00M | -$4.31M |
| Pretax Income | -$65.00M | -$2.26M |
| Net Income | -$171.00M | -$6.57M |
| EBITDA | $734.00M | -$1.98M |
| EPS (Diluted) | -$0.48 | -$0.07 |
Margins
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Operating Margin | 6.07% | -6.04% |
| Pretax Margin | -1.22% | -4.11% |
| Profit Margin | -3.21% | -10.5% |
| EBITDA Margin | 13.8% | -2.67% |
| FCF Margin | 2.57% | -0.30% |
Returns
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Return on Equity (ROE) | -2.67% | -19.2% |
| Return on Assets (ROA) | -1.24% | -13.3% |
| Return on Invested Capital (ROIC) | 2.30% | -4.11% |
| Return on Capital Employed (ROCE) | 2.70% | -9.07% |
Growth
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 8.85% | 8.85% |
| Revenue Growth (3Y CAGR) | 10.6% | 7.08% |
| Revenue Growth (5Y CAGR) | 8.38% | 11.8% |
Balance sheet
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $367.00M | $37.33M |
| Total Debt | $5.08B | $72.66M |
| Net Cash (Debt) | -$4.71B | $3.92M |
| Net Cash Per Share | -$13.19 | $0.28 |
| Equity (Book Value) | $6.38B | $57.36M |
| Book Value Per Share | $17.85 | $2.81 |
| Tangible Book Value | -$1.52B | $10.71M |
| Working Capital | $1.03B | $54.64M |
Financial position
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Current Ratio | 1.55 | 2.50 |
| Quick Ratio | 0.81 | 1.54 |
| Debt / Equity | 0.80 | 0.38 |
| Debt / EBITDA | 6.92 | 2.31 |
| Debt / FCF | 37.06 | 3.50 |
| Net Debt / EBITDA | 6.42 | 1.53 |
| Interest Coverage | 0.83 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Operating Cash Flow | $458.00M | -$653.46K |
| Capital Expenditures | -$321.00M | -$3.69M |
| Free Cash Flow | $137.00M | -$835.02K |
| FCF Per Share | $0.38 | -$0.02 |
Efficiency
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Asset Turnover | 0.38 | 0.59 |
| Revenue Per Employee | $409.54K | $322.57K |
| Profits Per Employee | -$13.15K | -$51.88K |
| Employee Count | 13,000 | 185 |
Dividends and yields
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Earnings Yield | -2.88% | -6.91% |
| FCF Yield | 2.31% | -0.56% |
Shares
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Shares Outstanding | 357,165,000 | 44,856,700 |
| Shares Change (YoY) | 0.59% | 3.35% |
| Shares Change (QoQ) | 0.19% | 0.27% |
| Float | 354,285,000 | 37,097,900 |
| Shares Held by Insiders | 0.81% | 10.6% |
| Shares Held by Institutions | 10.7% | 63.5% |
Taxes
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Income Tax | $98.00M | $1.52M |
Scores
| Measure | Bausch & Lomb | Industry median |
|---|---|---|
| Altman Z-Score | 0.93 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Bausch & Lomb's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.